Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapricorn Energy PLC Regulatory News (CNE)

Share Price Information for Capricorn Energy PLC (CNE)

Share Price is delayed by 15 minutes
Get Live Data
287.00    -3.00 (-1.03%)
Bid:
286.00
Ask:
290.00
Spread: 4.00 (1.399%)
Market Cap: £197.07m
CNE Live PriceLast checked at - London Stock Exchange

Intraday Capricorn Energy PLC Share Chart

Director/PDMR Shareholding

9 Apr 2025 10:57

RNS Number : 3259E
Capricorn Energy PLC
09 April 2025
 

FOR IMMEDIATE RELEASE 9 April 2025

 

 

 

CAPRICORN ENERGY PLC ("Capricorn" or "the Company")

 

 

Interests of Directors / Persons Discharging Managerial Responsibility ("PDMRs")

in the Company's Shares

 

1. Purchase of Partnership Shares / Award of Matching Shares under the Company's 2010 Share Incentive Plan (the "SIP")

 

Capricorn announces that, on 7 April 2025, the trustee (the "Trustee") of the Company's HMRC approved all-employee SIP purchased ordinary shares of 799/122 pence each in the Company ("Ordinary Shares") in the market at a price of £2.075 per Ordinary Share on behalf of participants in the "Partnership Share" element of the SIP using deductions made from their gross salary.

 

Capricorn also announces that, on 7 April 2025, awards of further Ordinary Shares were made to the participants under the "Matching Share" element of the SIP on the basis of two free Matching Shares for every one Partnership Share purchased. The Ordinary Shares used to satisfy these awards were previously purchased in the market.

 

Details of the PDMR who participated in the purchase / award are as follows:

 

 

PDMR

 

Number of Partnership Shares Purchased

Number of Matching Shares Awarded

Total Number of Shares Acquired

 

 

Nathan Piper, Commercial Director

 

72

144

216

 

In accordance with the rules of the SIP, Partnership and Matching Shares are initially held by the Trustee on the participants' behalf and, in the case of Matching Shares, must normally remain so held throughout a period of five years from the date of award. 

 

2. Summary of current holdings of PDMR

 

Following this announcement, Nathan Piper's beneficial interests in the Shares of the Company are as follows:

 

PDMR

Previous

Shares

Current Shares

% Issued Share Capital

Outstanding entitlements under 2017 LTIP and DBP

Awards still subject to performance conditions

Awards not subject to performance conditions*

Nathan Piper

8,130

8,346

0.01

406,918

8,891

 

 

 

 

 

* This column includes (i) all outstanding awards under the 2017 Long Term Incentive Plan ("2017 LTIP") that have vested following the expiry of the applicable performance period; and (ii) all outstanding awards under the Deferred Bonus Plan ("DBP"), the vesting of which is not subject to performance condition satisfaction.

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 as it forms part of domestic law by virtue of the European (Withdrawal) Act 2018.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nathan Piper

2

Reason for the notification

a)

Position/status

Commercial Director

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Capricorn Energy PLC

b)

LEI

213800ZJEUQ8ZOC9AL24

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 799/122 pence each

Identification code

GB00BNKT5L33

b)

Nature of the transaction

Partnership shares purchased under the Company's all-employee Share Incentive Plan (2010).

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.075

72

d)

Aggregated information

- Aggregated volume

- Price

 

 

- Not applicable

e)

Date of the transaction

7 April 2025

f)

Place of the transaction

London Stock Exchange

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 799/122 pence each

Identification code

GB00BNKT5L33

b)

Nature of the transaction

Matching shares awarded under the Company's all-employee Share Incentive Plan (2010) on the basis of two free matching shares for every one partnership share purchased.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.00

144

d)

Aggregated information

- Aggregated volume

- Price

 

 

- Not applicable

e)

Date of the transaction

7 April 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDSUUGDGUC
Date   Source Headline
5th May 20237:11 amRNSTransaction in Own Shares
4th May 20232:50 pmRNSTransaction in Own Shares
2nd May 20237:00 amRNSHolding(s) in Company
28th Apr 202312:09 pmRNSCirc re. Return of US$450 million to shareholders
28th Apr 20239:44 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSFull Year Results Announcement
17th Apr 20239:28 amRNSHolding(s) in Company
13th Apr 202310:04 amRNSHolding(s) in Company
11th Apr 20234:40 pmRNSDirector/PDMR Shareholding
11th Apr 202311:59 amRNSDirectorate Change
31st Mar 20233:06 pmRNSTotal Voting Rights
23rd Mar 20233:30 pmRNSCost base update
23rd Mar 20237:00 amRNSChange of Adviser
17th Mar 20239:20 amRNSDrilling/Production Report
28th Feb 20231:35 pmRNSTotal Voting Rights
27th Feb 20237:00 amRNSOperational, Trading and Business Update
22nd Feb 20234:09 pmRNSGM Statement
17th Feb 20232:00 pmRNSHolding(s) in Company
15th Feb 202310:31 amRNSUpdate on NewMed transaction and Strategic Review
14th Feb 20234:54 pmRNSDirector Declaration
1st Feb 20236:06 pmRNSNew Board to undertake Strategic Review
1st Feb 20233:20 pmRNSResult of Meeting
1st Feb 202311:56 amRNSResult of Meeting
31st Jan 20236:02 pmRNSPublication of Supplementary Prospectus & Circular
31st Jan 20232:19 pmRNSTotal Voting Rights
24th Jan 20237:10 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSBoard Changes
20th Jan 20232:25 pmRNSHolding(s) in Company
19th Jan 20238:11 amRNSHolding(s) in Company
17th Jan 20232:11 pmRNSLetter to shareholder Palliser
17th Jan 20238:16 amRNSHolding(s) in Company
16th Jan 202311:24 amRNSInvestor Update Presentation
13th Jan 20232:11 pmRNSPublication of a Prospectus
9th Jan 20237:02 amRNSPalliser Letter
9th Jan 20237:00 amRNSNotice of GM
5th Jan 202312:03 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSUpdate to Shareholders
4th Jan 202310:55 amRNSHolding(s) in Company
30th Dec 202211:13 amRNSTotal Voting Rights
29th Dec 20222:51 pmRNSHolding(s) in Company
28th Dec 20221:09 pmRNSHolding(s) in Company
28th Dec 20229:28 amRNSHolding(s) in Company
28th Dec 20229:22 amRNSHolding(s) in Company
22nd Dec 20224:02 pmRNSHolding(s) in Company
22nd Dec 20223:44 pmRNSHolding(s) in Company
22nd Dec 20228:11 amRNSHolding(s) in Company
22nd Dec 20228:04 amRNSHolding(s) in Company
20th Dec 202211:45 amRNSHolding(s) in Company
20th Dec 20229:57 amRNSHolding(s) in Company
19th Dec 20222:08 pmRNSInvestor Presentation and Shareholder Letter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.